378 related articles for article (PubMed ID: 26585211)
1. Macular Bruch Membrane Holes in Choroidal Neovascularization-Related Myopic Macular Atrophy by Swept-Source Optical Coherence Tomography.
Ohno-Matsui K; Jonas JB; Spaide RF
Am J Ophthalmol; 2016 Feb; 162():133-139.e1. PubMed ID: 26585211
[TBL] [Abstract][Full Text] [Related]
2. Macular Bruch Membrane Holes in Highly Myopic Patchy Chorioretinal Atrophy.
Ohno-Matsui K; Jonas JB; Spaide RF
Am J Ophthalmol; 2016 Jun; 166():22-28. PubMed ID: 27018232
[TBL] [Abstract][Full Text] [Related]
3. MACULAR BRUCH MEMBRANE DEFECTS IN HIGHLY MYOPIC EYES: The Beijing Eye Study.
You QS; Peng XY; Xu L; Chen CX; Wei WB; Wang Y; Jonas JB
Retina; 2016 Mar; 36(3):517-23. PubMed ID: 26818477
[TBL] [Abstract][Full Text] [Related]
4. Choroidal neovascularization secondary to pathological myopia-macular Bruch membrane defects as prognostic factor to anti-VEGF treatment.
Coelho J; Ferreira A; Abreu AC; Monteiro S; Furtado MJ; Gomes M; Lume M
Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2679-2686. PubMed ID: 33744983
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors of eyes with naïve subfoveal myopic choroidal neovascularization after intravitreal bevacizumab.
Yang HS; Kim JG; Kim JT; Joe SG
Am J Ophthalmol; 2013 Dec; 156(6):1201-1210.e2. PubMed ID: 24075429
[TBL] [Abstract][Full Text] [Related]
6. CORRESPONDENCE OF LEAKAGE ON FLUORESCEIN ANGIOGRAPHY AND OPTICAL COHERENCE TOMOGRAPHY PARAMETERS IN DIAGNOSIS AND MONITORING OF MYOPIC CHOROIDAL NEOVASCULARIZATION TREATED WITH BEVACIZUMAB.
Battaglia Parodi M; Iacono P; Bandello F
Retina; 2016 Jan; 36(1):104-9. PubMed ID: 26166803
[TBL] [Abstract][Full Text] [Related]
7. Subfoveal Choroidal Thickness Changes Following Anti-Vascular Endothelial Growth Factor Therapy in Myopic Choroidal Neovascularization.
Ahn SJ; Park KH; Woo SJ
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5794-800. PubMed ID: 26325418
[TBL] [Abstract][Full Text] [Related]
8. HOW VITREOMACULAR INTERFACE MODIFIES THE EFFICACY OF ANTI-VEGF THERAPY FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
Iacono P; Battaglia Parodi M; Iuliano L; Bandello F
Retina; 2018 Jan; 38(1):84-90. PubMed ID: 28098725
[TBL] [Abstract][Full Text] [Related]
9. Morphologic characteristics of macular complications of a dome-shaped macula determined by swept-source optical coherence tomography.
Ohsugi H; Ikuno Y; Oshima K; Yamauchi T; Tabuchi H
Am J Ophthalmol; 2014 Jul; 158(1):162-170.e1. PubMed ID: 24631474
[TBL] [Abstract][Full Text] [Related]
10. Peri-dome Choroidal Deepening in Highly Myopic Eyes With Dome-Shaped Maculas.
Ohno-Matsui K; Fang Y; Uramoto K; Shinohara K; Yokoi T; Ishida T; Jonas JB
Am J Ophthalmol; 2017 Nov; 183():134-140. PubMed ID: 28911990
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor gene and the response to anti-vascular endothelial growth factor treatment for choroidal neovascularization in high myopia.
Miyake M; Yamashiro K; Akagi-Kurashige Y; Kumagai K; Nakata I; Nakanishi H; Oishi A; Tsujikawa A; Yamada R; Matsuda F; Yoshimura N
Ophthalmology; 2014 Jan; 121(1):225-233. PubMed ID: 23953100
[TBL] [Abstract][Full Text] [Related]
12. CHOROIDAL THICKNESS AND CHORIORETINAL ATROPHY IN MYOPIC CHOROIDAL NEOVASCULARIZATION WITH ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Lee JH; Lee SC; Kim SH; Koh HJ; Kim SS; Byeon SH; Lee CS
Retina; 2017 Aug; 37(8):1516-1522. PubMed ID: 27798519
[TBL] [Abstract][Full Text] [Related]
13. Characteristic spectral-domain optical coherence tomography findings of multifocal choroiditis.
Vance SK; Khan S; Klancnik JM; Freund KB
Retina; 2011 Apr; 31(4):717-23. PubMed ID: 21386760
[TBL] [Abstract][Full Text] [Related]
14. APPLICATION OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY TO ASSESS ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN MYOPIC CHOROIDAL NEOVASCULARIZATION.
Cheng Y; Li Y; Huang X; Qu Y
Retina; 2019 Apr; 39(4):712-718. PubMed ID: 29256987
[TBL] [Abstract][Full Text] [Related]
15. Long-term functional and morphologic retinal changes after ranibizumab and photodynamic therapy in myopic choroidal neovascularization.
Parravano M; Ricci F; Oddone F; Missiroli F; De Felici C; Varano M
Retina; 2014 Oct; 34(10):2053-62. PubMed ID: 24946101
[TBL] [Abstract][Full Text] [Related]
16. Macular Bruch's membrane defect and dome-shaped macula in high myopia.
Fang Y; Jonas JB; Yokoi T; Cao K; Shinohara K; Ohno-Matsui K
PLoS One; 2017; 12(6):e0178998. PubMed ID: 28570624
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
Retina; 2007; 27(4):432-8. PubMed ID: 17420694
[TBL] [Abstract][Full Text] [Related]
18. Progression of myopic maculopathy after treatment of choroidal neovascularization.
Farinha CL; Baltar AS; Nunes SG; Figueira JP; Pires IA; Cachulo ML; Silva RM
Ophthalmologica; 2014; 231(4):211-20. PubMed ID: 24662778
[TBL] [Abstract][Full Text] [Related]
19. Spectral-Domain Optical Coherence Tomography of Subretinal Hyperreflective Exudation in Myopic Choroidal Neovascularization.
Bruyère E; Caillaux V; Cohen SY; Martiano D; Ores R; Puche N; Souied EH
Am J Ophthalmol; 2015 Oct; 160(4):749-58.e1. PubMed ID: 26164828
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization.
Yoon JU; Kim YM; Lee SJ; Byun YJ; Koh HJ
Retina; 2012 May; 32(5):949-55. PubMed ID: 22534553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
